In final draft guidance, UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has recommended the use of French drug major Sanofi subsidiary Genzyme's multiple sclerosis drug Lemtrada (alemtuzumab).
NICE is appraising alemtuzumab as a treatment for adults with relapsing & remitting multiple sclerosis, a chronic and disabling neurological condition that, as it progresses, can have a substantial negative impact on a person’s quality of life........ Read More - http://www.ms-uk.org/lemtrada
NICE says 'yes' to Genzyme's MS drug Lemtrada
NICE says 'yes' to Genzyme's MS drug Lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
-
Third course of Lemtrada improves MS patient’s relapse rate
by MSUK » Mon Mar 05, 2018 8:27 am » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 2613 Views
-
Last post by MSUK
Mon Mar 05, 2018 8:27 am
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in General Discussion - 0 Replies
- 1071 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 2098 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
- 1 Replies
- 919 Views
-
Last post by NHE
Wed Feb 07, 2018 11:27 pm
-
- 9 Replies
- 3676 Views
-
Last post by ElliotB
Wed Jan 09, 2019 1:55 pm
-
- 0 Replies
- 924 Views
-
Last post by seeva
Sat Dec 22, 2018 11:47 pm
-
- 0 Replies
- 111 Views
-
Last post by zen2010
Mon Dec 23, 2019 10:20 am
-
- 0 Replies
- 401 Views
-
Last post by ElliotB
Mon Mar 18, 2019 4:29 pm
-
-
Risks associated between MS drug natalizumab and pregnancy
by MSUK » Tue Feb 20, 2018 5:44 am » in Tysabri (Antegren or Natalizumab) - 0 Replies
- 1508 Views
-
Last post by MSUK
Tue Feb 20, 2018 5:44 am
-
